COMMUNIQUÉS West-GlobeNewswire

Ossur Hf : Results of the Annual General Meeting
08/03/2018
Announcement no. 17/2018 Reykjavik, 8 March 2018 Results of the Annual General Meeting Enclosed are the results of the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018. The Icelandic Register of [...]
Affimed to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
Heidelberg, Germany, March 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]
ViaDerma, Inc. Provides an Update of Current Marketing Activities
08/03/2018
LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), is pleased to provide an update of the Company’s current marketing activities: ViaDerma is in discussions with a Huntington Beach based [...]
Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.
08/03/2018
VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) (“Veritas” or the “Company”) is pleased to announce the signing of a non-binding Letter of [...]
C-RAD signs a contract for its GEMini portal imaging detector
08/03/2018
C-RAD announced today that it has signed an agreement with a Chinese company Beijing HGPT Technology & Trade Co., Ltd regarding the procurement and cooperation around the GEMini Portal imaging and dosimetry detector [...]
Execution, Growth and Increased Awareness
08/03/2018
In 2017, BioPorto remained focused on creating growth and ensuring tight execution of the top priorities in our strategic agenda; increasing awareness about the use of Neutrophil Gelatinase Associated Lipocalin (NGAL) [...]
Genmab A/S Summons Annual General Meeting
08/03/2018
Company Announcement Genmab A/S to hold Annual General Meeting on April 10, 2018 Copenhagen, Denmark; March 8, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) summons the Annual General Meeting on Tuesday, April 10, 2018 at [...]
Notice to convene Herantis Pharma Plc's Annual General Meeting of shareholders
08/03/2018
Notice to convene Herantis Pharma Plc's Annual General Meeting of shareholders Herantis Pharma Plc Company release 8 March 2018, 9:00 am NOTICE TO CONVENE HERANTIS PHARMA PLC'S ANNUAL GENERAL MEETING OF SHAREHOLDERS [...]
Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform
08/03/2018
Press Release Sources: Sanofi (EURONEXT: SAN) (NYSE: SNY) Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform Evotec-led platform open to academia, [...]
Evotec et Sanofi en négociations exclusives afin de créer, sous la direction d'Evotec, une plateforme R&D d'innovation ouverte dans les maladies infectieuses
08/03/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Evotec et Sanofi en négociations exclusives afin de créer, sous la direction d'Evotec, une plateforme R&D d'innovation ouverte dans les maladies [...]
INNATE PHARMA: consolidated financial results for the year ended December 31, 2017
08/03/2018
2017: CLINiCAL PROGRESS, Portfolio expansion and financial strength create the foundation for future growth Cash, cash equivalents and financial assets [a] amounted to €176.6m (million euros) as of December 31, 2017 [...]
Innate Pharma : résultats financiers consolidés au 31 décembre 2017
08/03/2018
2017 : progrès cliniques, augmentation du portefeuille et solidité financière : les fondations de la croissance Trésorerie, équivalents de trésorerie et actifs financiersa s'élevant à 176,6m€ (million d'euros) au 31 [...]
G1 Therapeutics Announces Pricing of Offering of Common Stock
08/03/2018
RESEARCH TRIANGLE PARK, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced the pricing of an underwritten public offering of 3,400,000 [...]
BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million
08/03/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, March 07, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRE SERVICES BriaCell Therapeutics Corp. ("BriaCell" or the "Company") ( [...]
Clearside Announces Pricing of Public Offering of Common Stock
08/03/2018
ALPHARETTA, Ga., March 07, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Immuron Reports Positive Results in NASH Clinical Trial
08/03/2018
Headlines: First-In Class Anti-LPS Mechanism of Action confirmed for IMM-124E Results demonstrate excellent safety and tolerability Statistically significant reduction in serum endotoxin/ Lipopolysaccharide (LPS) levels [...]
Immuron Limited Issues Correction to Misleading Halt Announcement Headline
07/03/2018
MELBOURNE, Australia, March 07, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ) (the “Company”) wishes to correct a misleading halt announcement released over the wire yesterday. The misleading [...]
Psychemedics Corporation Announces Q4 and Year End Results
07/03/2018
ACTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ) today announced fourth quarter and year-end financial results for the period ended December 31, 2017. The Company also announced a [...]
New Positive Data on Trogarzo™ (ibalizumab-uiyk) Injection and EGRIFTA® (tesamorelin for injection) Presented at 25th Conference on Retroviruses and Opportunistic Infections
07/03/2018
MONTREAL, March 07, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) today presented new results from additional analyses based on studies conducted with Trogarzo™ and EGRIFTA ® . The study [...]

Pages